Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
December 20, 2017 08:00 ET
|
Eloxx Pharmaceuticals
WALTHAM, Mass. and REHOVOT, Israel and SAN DIEGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals Ltd. (“Eloxx”) and Sevion Therapeutics, Inc. (OTCQB:SVON) (“Sevion”) today announced the two...
Eloxx Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial
November 27, 2017 08:00 ET
|
Eloxx Pharmaceuticals
Lead molecule targets genetic nonsense mutation in rare diseases Dose escalating study to enroll 36 subjects Data expected in the fourth quarter of 2018 SAN DIEGO and REHOVOT, Israel and BOSTON,...